副教授，硕士生导师，主持了国家自然科学基金和中国博士后科学基金面上项目。迄今在Signal Transduction and Targeted Therapy（IF=40.8）、 ACS Nano（IF=18.027）、Advanced Science (IF=14.7) 、Biomaterials（IF=15.304）、Theranostics（IF=11.6）、 Chemical Engineering Journal（IF=16.744）和Nano Today (IF=13.2) 等杂志发表学术论文30余篇。

09/2017–06/2020，暨南大学           博士

09/2011–06/2014，暨南大学           硕士 

09/2007-07/2011，广东药科大学    学士

07/2023-至今， 暨南大学化学与材料学院          副教授

07/2020-06/2023，暨南大学第一临床医学院      博士后

主要从事生物无机化学和化学生物学方向相关领域的研究工作

近年代表论文：

1. Shuoshan Li, Guizhen Li, Kexin Guo, Haimei Zhang, Haoqiang Lai*, Tianfeng Chen*. Cruciferae-based oral selenium delivery system reprograms antitumor response and enhances the anti-tumor potency of Natural killer cells. Nano Today.2025, 62, 102713.

2. Qian Xue#, Haoqiang Lai#, Haimei Zhang#, Guizhen Li, Fen Pi, Qifeng Wu, Siwei Liu, Fang Yang* and Tianfeng Chen*. Selenium Attenuates Radiation Colitis by Regulating cGAS-STING Signaling. Advanced Science. 2024, 11(44), e2403918.

3. Yanchao Xu, #, Haoqiang Lai #, Shuya Pan, Liuliu Pan, Ting Liu, Ziyi Yang, Tianfeng Chen*, Xueqiong Zhu*. Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation. Biomaterials.2024, 305, 122452.

4. Haoqiang Lai, Ligeng Xu*, Chang Liu, Sujiang Shi, Yalin Jiang, Yangyang Yu, Bo Deng, Tianfeng Chen*. Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine. Signal Transduction and Targeted Therapy. 2023, 8, 88.

5. Chang Liu #, Haoqiang Lai #, and Tianfeng Chen*. Boosting Natural killer cell-based cancer immunotherapy with selenocystine/transforming growth factor-beta inhibitor encapsulated nanoemulsion. ACS Nano. 2020, 14, 9, 11067–11082

6. Haoqiang Lai #, Xiaobin Zhang #, Zhenhuan Song, Zhongwen Yuan, Lizhen He⁎, Tianfeng Chen⁎. Facile synthesis of antioxidative nanotherapeutics using a microwave for efficient reversal of cisplatin-induced nephrotoxicity. Chemical Engineering Journal. 2020, 391,123563.

7. Haoqiang Lai, Delong Zeng, Chang Liu, Qi Zhang, Xuan Wang, Tianfeng Chen*. Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling. Biomaterials. 2019, 219, 119377.

8. Haoqiang Lai, Chang Liu, Liyuan Hou, Wenwei Lin, Tianfeng Chen* and An Hong*. TRPM8-regulated calcium mobilization plays a critical role in synergistic chemosensitization of borneol on doxorubicin. Theranostics. 2020, 10, 22.

9. Jinggong Liu #, Haoqiang Lai #, Zushuang Xiong, Bolai Chen and Tianfeng Chen. Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy. Chemical Communications. 2019,55, 9094. 

10. Zhen Chen #, Haoqiang Lai #, Liyuan Hou, Tianfeng Chen. Rational design and action mechanisms of chemically innovative organoselenium in cancer therapy, Chemical Communications. 2020, 56(2): 179-196. 

主持项目：

1. 国家自然科学基金青年科学基金项目，结题；

2. 中国博士后科学基金面上项目，结题；

3. 病毒致病及防控教育部重点实验室开放课题， 结题

参与项目：

1. 国家杰出青年科学基金项目

2. 国家重点研发计划-前沿生物技术专项

3. 国家高新技术研究发展计划（863计划）项目

《无机化学》、《化学生物学》、《无机化学实验》、《基础化学实验》